Biovian will attend BIO-Europe Spring 2015 from 9-11 March 2015 in Paris, France.
The company’s CEO, Dr Knut Ringbom will be available for in-depth discussions with delegates at the partnering offered at the conference.
Biovian provides GMP contract manufacturing of biopharmaceuticals covering services from early development to finished vials. The company’s 2300m² facilities are EMA and FDA certified for cGMP production of investigational and commercial products.
Biovian GMP services include:
- Microbial fermentation
- Mammalian cell culture
- Viral vector production
- Protein purification
- Aseptic fill and finish
- Analytical quality control services
- Stability studies
- Master cell banking
- Drug product labelling, packaging, storage and QP release
Biovian development services include cell line, process and analytical development.